Latest Articles

Publication Date
Canadian Biotech Afynia Raises $5M to Commercialize Blood Test for Endometriosis - Femtech Insider

Canadian Biotech Afynia Raises $5M to Commercialize Blood Test for Endometriosis Femtech Insider

Published: Feb. 27, 2025, 7:52 a.m.
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board Of Directors For Breach of Fiduciary Duties (PFE) - TradingView

INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board Of Directors For Breach of Fiduciary Duties (PFE) TradingView

Published: Feb. 27, 2025, 7:36 a.m.
Thoracic endometriosis syndrome diagnosed by dry thoracoscopy: Novel diagnostic method for a rare disease.

Endometriosis is an ectopic implantation of uterine tissue and can affect the thoracic cavity, resulting in Thoracic Endometriosis Syndrome (TES). TES is rare and presents with catamenial pneumothorax, haemothorax, and …

Published: Feb. 27, 2025, midnight
The long noncoding RNA LUCAT1 regulates endometrial receptivity via the miR-495-3p/S100P axis - Nature.com

The long noncoding RNA LUCAT1 regulates endometrial receptivity via the miR-495-3p/S100P axis Nature.com

Published: Feb. 26, 2025, 5:12 p.m.
Matildas, Made Up Endometriosis and Misogyny: Marty Sheargold's latest 'jokes' backfire - substack.com

Matildas, Made Up Endometriosis and Misogyny: Marty Sheargold's latest 'jokes' backfire substack.com

Published: Feb. 26, 2025, 6:18 a.m.
Small Bowel Obstruction Secondary to Endometriosis Affecting the Appendix in a Patient With a Virgin Abdomen.

A 62-year-old otherwise healthy Caucasian female patient presented to the emergency department with a one-day history of severe abdominal pain, accompanied by nausea and non-bloody emesis. She did not report …

Published: Feb. 26, 2025, midnight
University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis - TechCrunch

University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis TechCrunch

Published: Feb. 25, 2025, 5:10 p.m.
Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ – An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. - Markets Insider

Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ – An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. Markets Insider

Published: Feb. 25, 2025, 1:10 p.m.
Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ - An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. - The Manila Times

Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ - An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. The Manila Times

Published: Feb. 25, 2025, 10:48 a.m.
Thymic stromal lymphopoietin contributes to endometriotic lesion proliferation and disease-associated inflammation.

Endometriosis is a chronic disorder in which endometrial-like tissue presents outside the uterus. Patients with endometriosis have been shown to exhibit aberrant immune responses within the lesion microenvironment and in …

Published: Feb. 24, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!